Company insider dossier

IRIDEX Corporation insider intelligence

IRIX filings assessed for conviction, transaction quality, insider breadth, clustering, freshness, and price confirmation.

Terminal chart Weekly report Factor intelligence Healthcare Medical Devices Data API
81/100

Conviction accumulation

82/100 confidence
Exchange
NASDAQ
Sector
Healthcare
Industry
Medical Devices
Latest evidence
10 Sep 2026

Investment committee read

Conviction accumulation

Priced common-share acquisitions carry more weighted evidence than disposals after freshness, role, size, and duplicate controls.

Research constructive setups

Evidence in favour

  • 8 distinct acquisition events survive duplicate and security-type controls.
  • Participation spans 3 named insiders rather than one filing source.
  • The latest qualifying evidence is fresh, dated 10 Sep 2026.

Decision risks

  • Reported purpose is unavailable in this feed, so even priced common-share transactions need filing context.
Conviction81Conviction accumulation
Confidence82Deep evidence
Named insiders3participating in the tape
Controlled events11directional common-share events
Acquisition value$24.9Knormalized amount
Disposal value$26.9Knormalized amount

Price confirmation map

Weekly price with common-share events

Acquisitions and disposals are aligned to the nearest completed weekly bar.

1.521.301.090.880.66 Acquisition · 10 Sep 2026 · $3.5KAcquisition · 24 Aug 2026 · $973Acquisition · 10 Jul 2026 · Not reportedAcquisition · 10 Jul 2026 · Not reportedAcquisition · 7 Jul 2026 · Not reportedDisposal · 13 Jun 2026 · $4.5KDisposal · 13 Jun 2026 · $3.0KAcquisition · 12 Jun 2026 · $1.1KAcquisition · 11 Jun 2026 · $1.9KAcquisition · 8 Jun 2026 · $2.7KAcquisition · 5 Jun 2026 · $2.9KAcquisition · 3 Jun 2026 · $2.8KDisposal · 26 May 2026 · $19.4KAcquisition · 26 May 2026 · $5.0K
Mar 2025Sep 2026
Weekly closeCommon-share acquisitionCommon-share disposal

Market confirmation

Price and trend context

Latest close
0.66 USD
One-week move
-5.7%
Four-week move
-22.9%
Fair-value gap
-59.9%
Trend signal
Inactive
Relative strength
-45.2

Directional balance

Controlled event mix

72.7%acquisition
Acquisition events
8
Disposal events
3
Net value
-$2.0K

Cadence

Twelve-week filing pressure

Volume shows attention. Controlled events determine direction.

029 Jun
606 Jul
013 Jul
020 Jul
027 Jul
003 Aug
010 Aug
017 Aug
224 Aug
031 Aug
107 Sep
014 Sep

Named participants

Insider conviction by person

DIZON, ROMEO RChief Financial Officer849 events
NOVEL, INSPIRATION INTERNATIONAL CO., LTD.10% Owner500 events
MERCER, PATRICKDirector, President and CEO252 events

Evidence quality

Security and transaction context

Common equity14
Equity compensation1
Options and derivatives2
Other securities1

Role architecture

Who is participating

Finance leadership12
CEO and chair5
Large holder1

Transaction evidence

Auditable IRIX filing ledger

Showing 1 to 18 of 18.

DIZON, ROMEO RChief Financial Officer
AcquisitionCommon equity
5100 sharesCommon Stock
$3.5KDirectional evidence
DIZON, ROMEO RChief Financial Officer
AcquisitionOther securities
5368 sharesCommn Stock
$4.0KContext evidence
DIZON, ROMEO RChief Financial Officer
AcquisitionCommon equity
1300 sharesCommon Stock
$973Directional evidence
DIZON, ROMEO RChief Financial Officer
AcquisitionOptions and derivatives
170000 sharesStock option (right to buy)
Not reportedContext evidence
DIZON, ROMEO RChief Financial Officer
AcquisitionCommon equity
30000 sharesCommon Stock
Not reportedContext evidence
MERCER, PATRICKDirector, President and CEO
AcquisitionOptions and derivatives
200000 sharesStock option (right to buy)
Not reportedContext evidence
MERCER, PATRICKDirector, President and CEO
AcquisitionEquity compensation
100000 sharesPerformance Restricted Stock Units
Not reportedContext evidence
MERCER, PATRICKDirector, President and CEO
AcquisitionCommon equity
100000 sharesCommon Stock
Not reportedContext evidence
NOVEL, INSPIRATION INTERNATIONAL CO., LTD.10% Owner
AcquisitionCommon equity
111997 sharesCommon Stock
Not reportedContext evidence
MERCER, PATRICKPresident and CEO
DisposalCommon equity
3990 sharesCommon Stock
$4.5KDirectional evidence
DIZON, ROMEO RChief Financial Officer
DisposalCommon equity
2691 sharesCommon Stock
$3.0KDirectional evidence
DIZON, ROMEO RChief Financial Officer
AcquisitionCommon equity
975 sharesCommon Stock
$1.1KDirectional evidence
DIZON, ROMEO RChief Financial Officer
AcquisitionCommon equity
1675 sharesCommon Stock
$1.9KDirectional evidence
DIZON, ROMEO RChief Financial Officer
AcquisitionCommon equity
2400 sharesCommon Stock
$2.7KDirectional evidence
DIZON, ROMEO RChief Financial Officer
AcquisitionCommon equity
2521 sharesCommon Stock
$2.9KDirectional evidence
DIZON, ROMEO RChief Financial Officer
AcquisitionCommon equity
2400 sharesCommon Stock
$2.8KDirectional evidence
MERCER, PATRICKPresident and CEO
DisposalCommon equity
19233 sharesCommon Stock
$19.4KDirectional evidence
DIZON, ROMEO RChief Financial Officer
AcquisitionCommon equity
5004 sharesCommon Stock
$5.0KDirectional evidence

Reading the dossier

Direction and confidence are separate

Conviction

The 0 to 100 score classifies deduplicated priced common-share evidence. Fifty is balanced or non-directional.

Confidence

Confidence rises with controlled event depth, named-insider breadth, fresh evidence, normalized values, and a longer observation span.

Disposals

Selling is not treated as the mirror image of buying. It carries less directional weight because taxes, diversification, compensation, and planned transactions can all create sales.

Price confirmation

The market chart tests whether the filing thesis is being confirmed or rejected by price, fair-value position, relative strength, and the current trend state.

Independent market research for education. This classification is not investment advice, a recommendation, a forecast, or an execution instruction.

Evidence context